4//SEC Filing
FORMELA JEAN FRANCOIS 4
Accession 0000899243-21-049693
CIK 0001835579other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 6:43 PM ET
Size
5.9 KB
Accession
0000899243-21-049693
Insider Transaction Report
Form 4
FORMELA JEAN FRANCOIS
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-12-21+13,419→ 13,419 totalExercise: $14.92Exp: 2031-12-21→ Common Stock (13,419 underlying)
Footnotes (2)
- [F1]This option shall vest (1) 25% on December 21, 2022, and the remaining shall vest in equal monthly installments over the next 36 months.
- [F2]This option was granted to the Reporting Person, a director of the Issuer. The proceeds of any sale of shares of common stock issued to the Reporting Person upon exercise of this option will be transferred to Atlas Venture Life Science Advisors, LLC and as such, the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Ikena Oncology, Inc.
CIK 0001835579
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001030575
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 6:43 PM ET
- Size
- 5.9 KB